DDDD.L Share News (DDDD)

UK AGM, EGM Calendar - Week Ahead

4D Pharma Raises GBP34.8 Million Through Share Placing (ALLISS)

4d Pharma Posts First-Half Loss, Says Pipeline Is Strong

4D pharma progresses with IBS and Crohn's treatments

4D pharma has announced that its treatments for Irritable Bowel Syndrome (IBS) and Paediatric Crohn's Disease (PCD) are expected to enter clinical studies in the second quarter of 2015. The studies, which will be focused on evaluating safety and tolerability of the products as well as some clinica

UK MORNING BRIEFING: Weir Group Leads Firm London Market On Upgrade

4d Pharma's Blautix, Thetanix To Start Clinical Studies In 2015

4d Pharma Gets Orphan Drug Designation From US FDA

UK MORNING BRIEFING: Old Mutual, Coca-Cola HBC And RSA Weigh On FTSE

4d Pharma Buys Microbiota For GBP2.0 Million

UK MORNING BRIEFING: Shares Lower On Ukraine Crash, Gaza Offensive

4d Pharma Raises GBP21.5 Million In Share Placing

UK MORNING BRIEFING: Shares Down; Land Securities Buys Into Bluewater

4d Pharma Raises Stake In GT Biologics To 83.5%

LONDON (Alliance News) - 4d Pharma PLC Wednesday said it has acquired a further 37.5% stake in GT Biologics Ltd for GBP1.22 million in new 4d Pharma shares, taking its total shareholding in the GT Biologics to 83.5%. 4d Pharma, which focuses on significant new therapeutic areas, said the ac

4d pharma increases stake in GT Biologics to nearly 84%

4d pharma, an AIM-listed pharmaceutical company focused on new therapeutic areas, has added an additional 37.5% to its stake in GT Biologics taking its current holding to around 83.5%. The £1.22m consideration was satisfied by the issue of 699,500 new 4d shares at 175p each, reflecting their avera